Immunovant
IMVT
IMVT
40 hedge funds and large institutions have $194M invested in Immunovant in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+16
Holders Change %
+66.67%
% of All Funds
0.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
21
Increased
8
Reduced
7
Closed
5
Calls
$412K
Puts
–
Net Calls
+$412K
Net Calls Change
+$412K
Top Buyers
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$7.35M |
| 2 |
Millennium Management
New York
|
+$7.11M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.27M |
| 4 |
BlackRock
New York
|
+$4.72M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$3.89M |
Top Sellers
| 1 |
AC
Athanor Capital
New York
|
-$7.94M |
| 2 |
SCM
Sio Capital Management
New York
|
-$7.8M |
| 3 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$2.88M |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$1.61M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$1.4M |
